DEF 14A: 22nd Century Group Seeks Stockholder Approval for Reverse Stock Split and Warrant Issuance to Meet Nasdaq Requirements

Sentiment:

Proxy Statement


22nd Century Group is holding a special meeting to seek stockholder approval for a reverse stock split, warrant issuances, and debenture amendments to comply with Nasdaq listing rules and secure future financing.

Capital raiseThe company is seeking approval for the issuance of shares upon exercise of warrants, which would result in a capital raise.The company intends to use the net proceeds from any warrant exercises for general corporate purposes.The company may seek additional equity or debt financings in the future.
Worse than expectedThe company is seeking a reverse stock split to avoid delisting, indicating that the share price is below the required minimum.The company is seeking approval for the issuance of shares upon exercise of warrants at prices below the minimum price under Nasdaq rules.The company is seeking approval to reset the conversion price of debentures, potentially leading to significant dilution.

Summary

  • 22nd Century Group is convening a special meeting of stockholders on December 6, 2024, to vote on eight proposals.
  • The primary proposals involve a reverse stock split at a ratio between 1-for-2 and 1-for-250 to meet Nasdaq's minimum bid price requirement, as the company received a deficiency letter on July 16, 2024, for not complying with the $1.00 per share minimum.
  • Stockholders will also vote on approving the issuance of shares upon the exercise of several warrants issued between August and October 2024, as well as an amendment to outstanding convertible debentures.
  • These proposals aim to ensure compliance with Nasdaq listing rules, potentially increase the stock's attractiveness to investors, and secure additional financing for the company.
  • The record date for stockholders eligible to vote at the meeting is October 7, 2024.
  • As of October 7, 2024, there were 29,378,321 shares of common stock outstanding and entitled to vote.
  • As of October 18, 2024, the company had 42,544,987 shares of common stock issued and outstanding.
  • The current outstanding principal balance of the Debentures as of October 9, 2024 is approximately $8.3 million.

Sentiment

Score: 4

Explanation: The document outlines necessary measures to maintain Nasdaq listing compliance, but also highlights potential risks of dilution and financial instability. The sentiment is cautiously negative due to the company's need to undertake these actions.

Positives

  • A reverse stock split could increase the market price of the common stock, potentially attracting institutional investors and improving liquidity.
  • Approval of the warrant issuance proposals would allow the company to access capital through the exercise of these warrants.
  • The proposed actions aim to maintain the company's listing on the Nasdaq Capital Market.
  • The board has the flexibility to abandon the reverse stock split if market conditions are unfavorable.

Negatives

  • A reverse stock split may not result in a sustained increase in the stock price, and the total market capitalization could decrease.
  • Delisting from Nasdaq could negatively impact the ability to dispose of the company's common stock and raise additional capital.
  • The issuance of shares upon warrant exercises and debenture conversions could lead to significant dilution for existing stockholders.
  • The proposed amendment to the convertible debentures could result in a change of control of the company.
  • If the stockholders do not approve the proposals, the company will be obligated to incur additional management resources and expenses to call and hold a meeting every 75 or 90 days thereafter to seek such stockholder approval until the date Stockholder Approval is obtained.

Risks

  • The reverse stock split may not achieve the desired increase in stock price or maintain Nasdaq listing compliance.
  • Market conditions and the perception of the company's business could adversely affect the stock price, regardless of the reverse split.
  • Failure to obtain stockholder approval for the proposals could limit the company's access to capital and hinder its ability to fund operations.
  • The potential for significant dilution from warrant exercises and debenture conversions could negatively impact existing stockholders.
  • The company may have difficulty finding alternative sources of capital to fund its operations in the future on terms favorable to it or at all.

Future Outlook

The company intends to use the net proceeds from any warrant exercises for general corporate purposes. The company may seek additional equity or debt financings in the future.

Industry Context

Reverse stock splits are a common strategy for companies facing delisting from exchanges due to low stock prices. The company's actions reflect a broader trend of companies seeking to maintain exchange listings to enhance investor confidence and access to capital.

Comparison to Industry Standards

  • Many companies facing Nasdaq delisting have implemented reverse stock splits, including companies such as Farmmi, Inc. and Seanergy Maritime Holdings Corp.
  • The warrant inducement offering is similar to those conducted by other companies seeking to raise capital and restructure their outstanding warrants, such as those done by OceanPal Inc.
  • The potential for significant dilution from warrant exercises and debenture conversions is a common concern for companies utilizing these financing methods, as seen with companies like Verb Technology Company, Inc.

Stakeholder Impact

  • Shareholders face potential dilution from warrant exercises and debenture conversions.
  • Employees' stock options and equity-based compensation may be affected by the reverse stock split.
  • The company's ability to raise capital and fund operations could impact suppliers and creditors.
  • Customers may be affected by the company's financial stability and ability to invest in product development.

Next Steps

  • Stockholders will vote on the proposals at the Special Meeting on December 6, 2024.
  • The board will determine the reverse stock split ratio and whether to implement it based on market conditions.
  • The company will seek to obtain stockholder approval for the reduction in the Conversion Price by December 31, 2024, and every six months thereafter until approval is obtained.
  • The company will announce the preliminary voting results at the Special Meeting and release the final results in a Form 8-K within four business days following the Special Meeting.

Key Dates

DateDescription
March 3, 2023Company entered into Securities Purchase Agreement with JGB Partners, LP (JGB Partners), JGB Capital, LP (JGB Capital) and JGB Capital Offshore Ltd. (JGB Offshore and collectively with JGB Partners and JGB Capital, the Holders) and JGB Collateral, LLC, as collateral agent for the Holders (the Agent).
July 5, 2023The company effected a 1-for-15 reverse stock split of the company's issued and outstanding shares of common stock.
December 22, 2023The Company entered into an Amendment Agreement (the JGB Amendment) pursuant to which the Company agreed to amend the Debentures to allow the Holders to voluntarily convert the Debentures, in whole or in part, into shares of the Company's common stock (Voluntary Conversion Option).
April 2, 2024The company effected a 1-for-16 reverse stock split.
April 9, 2024Date of issuance of common stock purchase warrants to purchase 1,833,500 shares of common stock.
June 28, 2024Voluntary Conversion Option was approved by the Company's stockholders.
June 29, 2024The Conversion Price was set at $0.7458.
July 16, 2024Company received a deficiency letter from Nasdaq indicating non-compliance with the minimum bid price requirement.
August 27, 2024Company completed a private placement of warrants to purchase up 2,950,000 shares of common stock (the August Warrants) at an exercise price of $1.00 per share.
September 13, 2024Company completed private placement of warrants to purchase up 12,200,000 shares of common stock (the September 13 Warrants) at an exercise price of $1.00 per share.
September 27, 2024Company completed a private placement of warrants to purchase up to 10,307,016 shares of common stock and placement agent warrants to purchase up to 309,211 shares of common stock (the September 27 Warrants) at an exercise price of $1.00 per share for the common warrants and $1.25 per share for the placement agent warrants, respectively.
September 29, 2024Company commenced a warrant inducement offering with the holders of outstanding warrants to purchase 5,079,244 shares of common stock.
September 30, 2024Filing date of Current Report Form 8-K regarding the Inducement Warrants and September 27 Warrants.
October 7, 2024Record date for stockholders eligible to vote at the Special Meeting.
October 9, 2024Company entered into that certain Letter Agreement (Letter Agreement) with the Holders and Agent whereby the Company was granted the right, on a one-time basis, to reset the Conversion Price in effect.
October 11, 2024Company completed a private placement of warrants to purchase up to 28,533,332 shares of common stock and placement agent warrants to purchase up to 856,000 shares of common stock (the October 11 Warrants) at an exercise price of $1.00 per share for the common warrants and $1.25 per share for the placement agent warrants, respectively.
October 15, 2024Filing date of Current Report Form 8-K regarding the October 11 Warrants.
October 18, 2024Beneficial ownership information date.
October 22, 2024Last reported closing price of common stock was $0.1161.
October 25, 2024Date of the proxy statement.
December 5, 2024Deadline for submitting proxies by telephone or internet (11:59 p.m. EDT).
December 6, 2024Date of the Special Meeting of Stockholders.
December 30, 2024Deadline for stockholder proposals for the 2025 Annual Meeting.
December 31, 2024Deadline for seeking stockholder approval for the reduction in the Conversion Price.
January 13, 2025Deadline to regain compliance with Nasdaq's minimum closing bid price requirement.

Keywords

reverse stock split, warrant issuance, Nasdaq listing, convertible debentures, stockholder approval, dilution, minimum bid price, capital raising, proxy statement, common stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.